FDA clears first human trial of epigenetic reprogramming therapy
A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…
Life Bio: epigenetic rejuvenation ‘transcends organs’
Longevity biotech presents data demonstrating therapeutic impact of partial epigenetic reprogramming across multiple biological systems. Today at the…